Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Avatar Builder  |  Contact Info  |  Update Email  |  Update Password  |  Leaderboards  |  Manage Favourite  |  Reputation  |  Reputation History  |  Subscriptions  |  Payment Info  |  Invoices  |  Favourites

Bullboard Post History

by peterm

T.CUS.DB.D

RE:RE:RE:Canexus closes Private Placement...

Still waiting for Phoenix_trader................This won't be resolved...

September 21, 2016

T.CUS.DB.D

mattmckenzie

Hard to believe someone could be more annoying than Kherson. Congrats. You...

September 8, 2016

T.CUS.DB.D

RE:RE:4 weeks left...

mattmckenzie you can join kherson on ignore. ba bye.

May 28, 2016

T.CUS.DB.D

RE:RE:RE:Book value was 11 cents a share as of June 30th...

Does anyone have an answer to Khersons question without bringing up the usual...

September 18, 2015

T.CUS.DB.D

RE:The invisible hand @ $1.37/1.38.

First time you haven't been right. Also first time I wish you were right....

July 7, 2015

T.CUS.DB.D

June 19th - 6mil shares traded

Anybody know what's up? North Van announcement? Very unusual volume.

June 19, 2015

T.CUS.DB.D

NATO SOLD - Wait for it $75M

Enough said. What a joke.

June 4, 2015

T.CUS.DB.D

Dead Cat?

Well someone's buying. Thankfully. Honesty/Dishonesty, gotta admit I sure...

March 24, 2015

T.CUS.DB.D

RE:Can we please....

Ocean I value your input. Kherson you also do provide some input BUT there is...

February 26, 2015

T.CUS.DB.D

RE:RE:RE:Shot across the Bow...

Although Kherson's unrelenting repetitious negativity wears on me at...

January 24, 2015

T.CUS.DB.D

Problem ain't Kherson - problem is CUS

Kherson bashing at this time in wake of some pending bad news seems...

January 6, 2015

T.CUS.DB.D

RE:Short position

Sorry for my lack of knowledge but what does this chart actually tell us. I...

December 19, 2014

T.CUS.DB.D

RE:RE:RE:RE:Where is Nawar?

Maybe Nawar's the one dumping right at the opening every day. He has...

December 3, 2014

T.CUS.DB.D

MEG down 25%

MEG is down 25% over the last few days. Their bullying days of Canexus should...

November 29, 2014

T.CUS.DB.D

Q3 Results

Wow - No div cut - obviously lower numbers but let the experts cut at it.

November 6, 2014

T.CUS.DB.D

Personnel Changes Senior VP Operations Out

Is this the start of running for cover just before 3rd quarter results come...

October 28, 2014

T.CUS.DB.D

RE:RE:RE:Rebuilding Confidence and Performance, 2013 Annual Report

Kherson you do tend to be awfully negative about every stock you own. BUT his...

October 22, 2014

T.CUS.DB.D

RE:September 2014 Presentation Is Available

thanks for posting. I read and reread presentation, especially second last...

September 23, 2014

T.CUS.DB.D

RE:Meg

It wouldn't hurt them. MEG never acknowledged the court action. Check...

September 9, 2014

T.CUS.DB.D

Doug Wonnacott

I hope I'm not being overly optomistic but from here on CUS should...

September 8, 2014

1 2 Next

Featured Company

Algernon Pharmaceuticals Inc.

Algernon Pharmaceuticals Inc. C.AGN

Algernon Pharmaceuticals Inc. is a clinical-stage drug development company. The Company is focused on developing repurposed ... view more »